feed,title,long_url,short_url
r/science:15+,"[Cancer] The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low tumours",https://redd.it/n7xpya,
